1. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer 
Nami Ueki, MD, Yukinori Matsuo, MD, PhD, Yosuke Togashi, MD, Takeshi Kubo, MD, Keiko Shibuya, MD, PhD, Yusuke Iizuka, MD, Takashi Mizowaki, MD, PhD, Kaori Togashi, MD, PhD, Michiaki Mishima, MD, PhD, Masahiro Hiraoka, MD, PhD 
Journal of Thoracic Oncology 
Volume 10, Issue 1, Pages (January 2015)
DOI: /JTO
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Cumulative incidence of radiation pneumonitis worse than grade 2 (≥Gr2 RP) (A), and worse than grade 3 (≥ Gr3 RP), (B), are shown in those with ILD (ILD[+]) and those without ILD (ILD[−]).ILD, interstitial lung disease.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
CT images of the patients who had significant ILD findings and underwent SBRT for lung cancer situated in left segment 6. Before SBRT (A), and (B), on 5 days after the completion of SBRT when diagnosed as the acute exacerbation of ILD.CT, computed tomography, ILD, interstitial lung disease; SBRT, stereotactic body radiation therapy.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

4. FIGURE 3
A, Overall survival rate, (B) incidence of disease progression, and (C) incidence of local progression are shown in those with ILD (ILD[+]) and those without ILD (ILD[−]). ILD, interstitial lung disease.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions